Efficacy of Omalizumab for the treatment of Bullous Pemphigoid. Spanish multicenter real-world experience.

Álvaro Aguado VázquezAndrea Estébanez CorralesF Javier Melgosa-RamosJosé Manuel Mascaró GalyJon Fulgencio-BarbarinXavier Bosch AmateLaia Curto BarredoMar Blanes-MartínezRicardo Ruiz VillaverdeAsunción Ballester MartínezDaniel Martín-TorregrosaJuan Luis Castaño FernándezRita Cabeza MartínezAmparo Pérez-FerriolsDaniel Ramos RodríguezJulian Boix VilanovaGemma Melé-NinotVicente Expósito SerranoAgustin España AlonsoAlmudena Mateu-Puchades

Published in: Clinical and experimental dermatology (2024)

Omalizumab is a good therapeutic alternative for BP as it obtained clinical response in most patients and nearly half of the cases achieving complete response. It showed no side effects which is crucial in elderly patients suffering from BP.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
cross sectional
patient reported outcomes
combination therapy
double blind